Dancygier H, Nattermann C
Medizinische Klinik II der Städtischen Kliniken Offenbach.
Praxis (Bern 1994). 1994 Nov 15;83(46):1281-7.
Based on own experience and on published data we report about indications and efficacy of endoscopic ultrasonography (EUS) in esophageal and gastric diseases. At the present time the following conclusions can be drawn: Submucous tumors can be clearly demonstrated and unequivocally distinguished from extramural compressions. Although the EUS aspect does not allow to differentiate benign from malignant lesions, EUS findings can give hints as to the nature of a submucous tumor (leiomyoma, lipoma, cyst). The main indication for EUS ist local tumor staging. The pT stage of esophageal carcinoma can be assessed correctly in 84% (73 to 92%) and that of gastric carcinoma in 80% (69 to 92%) of the cases by EUS. Especially in early tumor stages, EUS is superior to computed tomography. Regional lymph node metastases can be visualized in 70 to 90% of the cases. EUS is also helpful in the follow-up of patients with operative resection of esophageal cancer and in patients with gastric non-Hodgkin lymphoma during radio-/chemotherapy.
基于我们自己的经验和已发表的数据,我们报告了内镜超声检查(EUS)在食管和胃部疾病中的适应证及疗效。目前可得出以下结论:黏膜下肿瘤能够被清晰显示,并与壁外压迫明确区分。尽管EUS表现无法区分良性与恶性病变,但EUS检查结果可提示黏膜下肿瘤(平滑肌瘤、脂肪瘤、囊肿)的性质。EUS的主要适应证是局部肿瘤分期。通过EUS,食管癌的pT分期在84%(73%至92%)的病例中可被正确评估,胃癌的pT分期在80%(69%至92%)的病例中可被正确评估。尤其在肿瘤早期阶段,EUS优于计算机断层扫描。70%至90%的病例中可发现区域淋巴结转移。EUS对接受食管癌手术切除的患者以及接受放化疗的胃非霍奇金淋巴瘤患者的随访也有帮助。